Skip to main content
Equibles

NVO · Novo Nordisk A S · Metrics

Track NVO — free

Use NVO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NVO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$38.64 +0.46 (+1.20%) At close · Oct 9
Rebalance outlook locked
Market Cap
$170.57B
Shares
4.41B
Volume · Oct 9 9.65M Avg daily vol (3M) 12.59M

NVO metrics

80 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$38.64
Market cap
$170.57B

Price action

20 metrics
Price change (1W)
+3.5%
Price change (30D)
-10.3%
Price change (3M)
-21.9%
Price change (6M)
+3.0%
Price change (YTD)
-24.1%
Price change (1Y)
-34.2%
Trailing year
Price change (5Y)
—
52-week high
$63.98
52-week low
$35.29
Change from 52-week high
-39.6%
Change from 52-week low
+9.5%
Annualized volatility
45.8%
Annualized volatility (3M)
37.7%
Beta
1.1
RSI (14D)
37.9
Price vs SMA 50
-11.0%
Price vs SMA 200
-14.9%
Avg volume (3M)
12.59M
Relative volume
0.8
Average dollar volume
$554.99M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
4.41B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.6×
reciprocal yield 27.8%
EV / EBITDA
—
EV / EBIT
8.3×
reciprocal yield 12.0%
P / sales
3.3×
reciprocal yield 30.2%
P / book
5.0
reciprocal yield 19.8%
FCF yield
6.9%
TTM · current market cap
Buyback yield
0.5%
P / FCF
14.4
reciprocal yield 6.9%
P / operating cash flow
8.3
reciprocal yield 12.1%
Earnings yield
10.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
4.8%
Trailing 12 months
Payout ratio
44.6%
Shareholder yield
5.3%
Dividend / share (TTM)
$1.85
Dividend growth YoY
+10.2%
Dividend growth streak
5
Last ex-dividend
2026-08-17

Earnings calendar

2 metrics
Next earnings
2027-02-03
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
80.6%
Operating margin
43.1%
Trailing 12 months
Net margin
35.3%
Gross profit (TTM)
$265.68B
Operating profit (TTM)
$142.10B
Net income (TTM)
$18.20B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
23.0%
Effective tax rate
-21.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+2.1%
Year over year
Net income growth YoY
-20.8%
Revenue (TTM)
$51.45B
Trailing 12 months
EPS growth YoY
-20.3%
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
+20.4%
Revenue CAGR (5Y)
+19.5%
EPS CAGR (3Y)
+23.5%
EPS CAGR (5Y)
+20.7%
FCF CAGR (3Y)
-4.0%
FCF CAGR (5Y)
+5.0%

Quality

14 metrics
Return on equity
52.6%
Return on assets
19.6%
Debt / equity
0.6
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
$11.84B
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$14.54B
Latest balance sheet
Cash & equivalents
$6.80B
Total assets
$90.89B
Total debt
$21.41B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$20.59B
Capital expenditures (TTM)
$8.75B
R&D (TTM)
$7.18B
SG&A (TTM)
−$10.13B
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
1,369
13F filer change QoQ
+79
Institutional ownership
9.3%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 353278 CUSIP 670100205 13F (30d) 90 filings 76 filers Visit website Investor relations